Guardion Health Sciences Inc

Guardion Health Sciences — Investor Presentation (March 2021)

20 slides from Guardion Health Sciences's investor presentation, Mar 16, 2021

  1. Slide 1: Corporate Presentation

    HEALTH SCIENCES Corporate Presentation Nasdaq: GHSI March 2021

  2. Slide 2: Forward Looking Statement

    FORWARD LOOKING STATEMENT This presentation of Guardion Health Sciences, Inc. (the “company,” “Guardion,” “we,” “us,” or “our”) includes "forward-looking statements" intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These stat

  3. Slide 3: About Guardion Health Sciences

    About Guardion Health Sciences Guardion Health Sciences (NASDAQ: GHS]), is a clinical nutrition and diagnostics company. GHSI offers a portfolio of science-based, clinically supported nutritional supplements, medical foods, and diagnostic products that support healthcare professionals, their patient

  4. Slide 4: Investment Highlights

    Investment Highlights Ye Differentiated and established product portfolio of proven nutrition, medical foods, and diagnostic devices with a historical focus in ocular health and immune health *“* Commercial-stage products with potential to scale revenue in both U.S. and foreign markets “* Strong pro

  5. Slide 5: Nutrition — Large, Growing, Global Market

    Nutrition — Large, Growing, Global Market All segments - supplements, clinical nutrition & medical foods - showing strong growth Global Supplement and Medical Food Market Global Players cosh] @ Size and Growth (2020- 2030) 350 Eye Health _~ 300 - 1.3 Medical Food fl 6.1 Eye Health ems 2 250 Suppleme

  6. Slide 6: Clinical Nutrition Industry

    Clinical Nutrition Industry VITAMINS & SUPPLEMENTS > Evidence Based CLINICALLY Abbott UA resents SUPPORTED > Clinically Supported Nutrition KABI NUTRITION —_— > Medically Endorsed/Supervised «Nestlé o HealthScience PHARMACEUTICALS Nasdaq: GHSI

  7. Slide 7: Growth Drivers of Clinically Supported Nutrition

    Growth Drivers of Clinically Supported Nutrition (s Increasing awareness of the importance of nutrition >) ** Growing body of research demonstrating benefits of nutrition “+ Increasing geriatric population with unique nutritional needs “+ Increasing rate of chronic illness that may benefit from nutr

  8. Slide 8: Ocular Health

    Ocular Health Nasdaq: GHSI GUARDION

  9. Slide 9: Opportunity in the Large Ocular Health Sector

    Opportunity in the Large Ocular Health Sector The ocular nutrition market is expected to grow at a 6% CAGR, driven by Age-related Macular Degeneration (“AMD”) and glaucoma, which are primary treatment focus areas of Guardion Market Value (US $ Bn) Re oO RB a oN 4.0 0.8 02 i q2 14 2020 = AMD = Dry Ey

  10. Slide 10: Company's Ocular Health Products

    Company's Ocular Health Products Lumega-Z (“LMZ”): Designed to replenish and restore the macular protective pigment. A depleted macular pigment is a risk factor for macular degeneration HEALTH SCIENCES GlaucoCetin Designed to support and protect the mitochondrial function of optic nerve cells and im

  11. Slide 11: Ocular Health Growth Initiatives

    Ocular Health Growth Initiatives *Grow the current customer base by leveraging technology to increase awareness + Increase consumer awareness with increased marketing ** Improve the customer experience “Strengthen relationship with eye care providers “* Highly-targeted virtual education programs to

  12. Slide 12: Immune Health

    Immune Health Nasdaq: GHSI GUARDION

  13. Slide 13: Opportunity in A Growing Sector

    Opportunity in A Growing Sector Immune Health $37.7 Billion Key Market Drivers 40 oo + Increasing health consciousness and awareness of & 35 zg ee nutrition among patients and providers Za #” 30 & 2) oF + Growing at-risk geriatric population 2 25 8 20 + Rising rate of chronic immune illnesses O > o

  14. Slide 14: Company's Immune Health Products

    Company's Immune Health Products HEALTH SCIENCES (i } +S _— 4 F a F r = = NutriGuard ImmuneSF Astramern Astra H Astramern Astra V Nutritional supplement Malaysia Customized, Malaysia Customized, product developed “private label” product “private label” product under the Nutriguard that contains spec

  15. Slide 15: Immune Health Growth Initiatives

    Immune Health Growth Initiatives **Grow the current customer base by leveraging technology to increase svareness \ “Expand distribution via third party eCommerce platforms “Improved technology interface (GHSI website, GHSI eCommerce platform, etc.) “Evaluate international markets to increase sales “

  16. Slide 16: Growth Strategy

    Growth Strategy GUARDION

  17. Slide 17: Current Growth Initiatives

    Current Growth Initiatives i. Evaluate merger and acquisition opportunities “+ Build product portfolio “+ Build and strengthen distribution channels * Accelerate and diversify top line revenue and EBITDA *» Accelerate Digital Solutions/Digital Platform *» Accelerate evidence-based initiatives “ Imme

  18. Slide 18: Current Growth Initiatives (continued)

    Current Growth Initiatives (continued) 4. Strengthen clinical evidence to create differentiation *» New studies to demonstrate the value of Lumega-Z for a wider range of macular degeneration patients “» New studies show benefit of Lumega-Z for other conditions: glaucoma and diabetic retinopathy *» F

  19. Slide 19: Leadership Team

    Leadership Team Bret Scholtes David W. Evans, PhD Andrew Schmidt Susan Klein, ND Director Director Vice President and Chief Director of Chief Executive Officer Chief Science Officer Financial Officer Medical Education President Robert N. Weingarten Mark Goldstone Kelly J. Anderson Director Donald A.

  20. Slide 20: For More Information

    HEALTH SCIENCES FOR MORE INFORMATION: Investor Relations CORE IR Scott Arnold (516) 222-2560 scotta@coreir.com guardionhealth.com Nasdaq: GHSI GUARDION

Guardion Health Sciences — Investor Presentation (March 2021) on 6ix